{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:41:00Z","timestamp":1768927260442,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Genome sharing between cancer and normal tissues might imply a similar susceptibility to chemotherapy toxicity. The present study aimed to investigate whether curative potential of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) is predicted by the metabolic response of normal tissues in patients with Hodgkin lymphoma (HL). METHODS: According to current guidelines, 86 patients with advanced-stage (IIB-IVB) HL, prospectively enrolled in the HD0607 trial (NCT00795613), underwent 18 F-fluorodeoyglucose PET\/CT imaging at diagnosis and, at interim, after two ABVD courses, to decide regimen maintenance or its escalation. In both scans, myocardial FDG uptake was binarized according to its median value. Death and disease relapse were recorded to estimate progression-free survival (PFS) during a follow-up with median duration of 43.8 months (range 6.97\u201360). RESULTS: Four patients (4.6%) died, while six experienced disease relapse (7%). Complete switch-off of cancer lesions and cardiac lighting predicted a favorable outcome at Kaplan\u2013Mayer analyses. The independent nature and additive predictive value of their risk prediction were confirmed by the multivariate Cox regression analysis. CONCLUSION: Susceptibility of HL lesions to chemotherapy is at least partially determined by factors featuring the host who developed it.<\/jats:p>","DOI":"10.3390\/biomedicines9080971","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T05:22:01Z","timestamp":1628227321000},"page":"971","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Myocardial Metabolic Response Predicts Chemotherapy Curative Potential on Hodgkin Lymphoma: A Proof-of-Concept Study"],"prefix":"10.3390","volume":"9","author":[{"given":"Cecilia","family":"Marini","sequence":"first","affiliation":[{"name":"Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"},{"name":"CNR Institute of Molecular Bioimaging and Physiology (IBFM), 20090 Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1937-9116","authenticated-orcid":false,"given":"Matteo","family":"Bauckneht","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Borra","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Informatics, Bioengineering, Robotics and Systems Engineering (DIBRIS), University of Genoa, 16128 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabella","family":"Donegani","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Miceli","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-8554","authenticated-orcid":false,"given":"Cristina","family":"Campi","sequence":"additional","affiliation":[{"name":"LISCOMP Lab., Department of Mathematics (DIMA), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Cossu","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Schenone","sequence":"additional","affiliation":[{"name":"LISCOMP Lab., Department of Mathematics (DIMA), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Morbelli","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"},{"name":"Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4394-5031","authenticated-orcid":false,"given":"Stephane","family":"Chauvie","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, S. Croce Hospital, 12100 Cuneo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Piana","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"},{"name":"LISCOMP Lab., Department of Mathematics (DIMA), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gallamini","sequence":"additional","affiliation":[{"name":"Research and Clinical Innovation Department, Antoine Lacassagne Cancer Center, 06189 Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-6500","authenticated-orcid":false,"given":"Gianmario","family":"Sambuceti","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy"},{"name":"Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.6004\/jnccn.2020.0026","article-title":"Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Hoppe","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.2017.75.2543","article-title":"Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography\/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL\/FIL HD 0607 Trial","volume":"36","author":"Gallamini","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","article-title":"FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma","volume":"107","author":"Hutchings","year":"2006","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","article-title":"Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: A report from a joint Italian-Danish study","volume":"25","author":"Gallamini","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","article-title":"PET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): Final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group","volume":"390","author":"Borchmann","year":"2017","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ehf2.12475","article-title":"Evidence for a cardiac metabolic switch in patients with Hodgkin\u2019s lymphoma","volume":"6","author":"Heckmann","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12967-018-1670-9","article-title":"An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline","volume":"16","author":"Sarocchi","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.117.191122","article-title":"Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET\/CT Observation","volume":"58","author":"Bauckneht","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bauckneht, M., Morbelli, S., Fiz, F., Ferrarazzo, G., Piva, R., Nieri, A., Sarocchi, M., Spallarossa, P., Canepari, M.E., and Arboscello, E. (2017). A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility. Diagnostics (Basel), 7.","DOI":"10.3390\/diagnostics7040057"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13550-020-0607-5","article-title":"Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: A computational approach to [18F]-fluorodeoxyglucose PET\/CT images","volume":"10","author":"Bauckneht","year":"2020","journal-title":"EJNMMI Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3816\/CLM.2004.n.012","article-title":"Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin\u2019s lymphoma can simulate lymphoma involvement in marrow","volume":"5","author":"Elstrom","year":"2004","journal-title":"Clin. Lymphoma."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/01.rlu.0000246858.03018.0c","article-title":"FDG PET\/CT flip flop phenomenon in treated lymphoma of bone","volume":"31","author":"Lin","year":"2006","journal-title":"Clin. Nucl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00259-005-1890-0","article-title":"Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow","volume":"32","author":"Kazama","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2967\/jnumed.109.073197","article-title":"18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma","volume":"51","author":"Cerci","year":"2010","journal-title":"J. Nucl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2007-09-112128","article-title":"Proteomics analysis of Hodgkin lymphoma: Identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes","volume":"111","author":"Ma","year":"2008","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3324\/haematol.2010.024885","article-title":"Positron emission tomography scanning: A new paradigm for the management of Hodgkin\u2019s lymphoma","volume":"95","author":"Gallamini","year":"2010","journal-title":"Haematologica"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s12350-019-01618-x","article-title":"Increased myocardial 18F-FDG uptake as a marker of Doxorubicin-induced oxidative stress","volume":"27","author":"Bauckneht","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1158\/1078-0432.CCR-13-3373","article-title":"Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity","volume":"20","author":"Khiati","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: Challenges and opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12410-019-9517-1","article-title":"FDG-PET Imaging of Doxorubicin-Induced Cardiotoxicity: A New Window on an Old Problem","volume":"12","author":"Bauckneht","year":"2019","journal-title":"Curr. Cardiovasc. Imaging Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1600-0773.2003.930301.x","article-title":"Doxorubicin-induced cardiac mitochondrionopathy","volume":"93","author":"Wallace","year":"2003","journal-title":"Pharmacol. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s00259-021-05368-2","article-title":"18 F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at?","volume":"48","author":"Sambuceti","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working","volume":"32","author":"Barrington","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2967\/jnumed.112.110890","article-title":"International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: Interpretation criteria and concordance rate among reviewers","volume":"54","author":"Biggi","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s00259-012-2141-9","article-title":"Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET\/CT imaging","volume":"39","author":"Sambuceti","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1182\/blood-2015-01-618215","article-title":"Allogeneic cell transplant expands bone marrow distribution by colonizing previously abandoned areas: An FDG PET\/CT analysis","volume":"125","author":"Fiz","year":"2015","journal-title":"Blood"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/971\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:41:34Z","timestamp":1760164894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["biomedicines9080971"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9080971","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]}}}